Literature DB >> 9782255

Treatment of cerebral radionecrosis by hyperbaric oxygen therapy.

K A Leber1, H G Eder, H Kovac, U Anegg, G Pendl.   

Abstract

Clinically observed adverse radiation effects (ARE) are rather uncommon, but modern imaging reveals that they are more common after radiosurgery than previously believed. Little is known about the pathogenesis, and current treatment is mostly empirical. The benefit of hyperbaric oxygen therapy (HBO) on radiation-induced bone and soft tissue necrosis is known in lesions in the maxillofacial area, the mouth and in the head and neck. HBO raises the tissue pO2 and initiates a cellular and vascular repair mechanism. This forms the basis for the hypothesis that it might also help alleviate the results of cerebral radionecrosis. This study is a preliminary attempt to test this hypothesis. Two patients with arteriovenous malformations (AVMs) were chosen for the study. They had been treated with Gamma Knife radiosurgery (GKRS) and had developed imaging signs consistent with ARE. They were treated by breathing 100% oxygen at 2.5 atmospheres absolute (250 kPa) in sessions of 60 minutes per day. This treatment was repeated 40 times in cycles of ten sessions. Both responded well to HBO, one lesion disappeared and the other was reduced significantly in size. No adjuvant steroids were given. These results give evidence that HBO has a potential value in treating ARE but further experience will be needed to confirm its definite benefit.

Entities:  

Mesh:

Year:  1998        PMID: 9782255     DOI: 10.1159/000056426

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  23 in total

Review 1.  Acute hemorrhage in late radiation necrosis of the temporal lobe: report of five cases and review of the literature.

Authors:  K M Cheng; C M Chan; Y T Fu; L C Ho; F C Cheung; C K Law
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

Review 2.  [Neurological complications of neurooncological therapy].

Authors:  U Herrlinger; J P Steinbach
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

Review 3.  Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology.

Authors:  Alba A Brandes; Alicia Tosoni; Federica Spagnolli; Giampiero Frezza; Marco Leonardi; Fabio Calbucci; Enrico Franceschi
Journal:  Neuro Oncol       Date:  2008-04-09       Impact factor: 12.300

4.  An analysis of radiation necrosis of the central nervous system treated with bevacizumab.

Authors:  Karen Tye; Herbert H Engelhard; Konstantin V Slavin; M Kelly Nicholas; Steven J Chmura; Young Kwok; Dominic S Ho; Ralph R Weichselbaum; Matthew Koshy
Journal:  J Neurooncol       Date:  2014-02-07       Impact factor: 4.130

5.  Clinical, dosimetric, and radiographic correlation of radiation injury involving the brainstem and the medial temporal lobes following stereotactic radiotherapy for neoplasms of central skull base.

Authors:  Stefano Schipani; Rajan Jain; Keyur Shah; Jack P Rock; Benjamin Movsas; Mark Rosenblum; Samuel Ryu
Journal:  J Neurooncol       Date:  2010-04-08       Impact factor: 4.130

6.  Double trouble: a tale of two radio-treatments.

Authors:  Ebere Sunny Ogbonnaya; Nikolay Peev; Sanjoy Nagaraja; Ronan Dardis
Journal:  BMJ Case Rep       Date:  2014-09-19

Review 7.  Managing the cognitive effects of brain tumor radiation therapy.

Authors:  Jerome M Butler; Stephen R Rapp; Edward G Shaw
Journal:  Curr Treat Options Oncol       Date:  2006-11

8.  Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.

Authors:  Roy Torcuator; Richard Zuniga; Yedathore S Mohan; Jack Rock; Thomas Doyle; Joseph Anderson; Jorge Gutierrez; Samuel Ryu; Rajan Jain; Mark Rosenblum; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2009-02-03       Impact factor: 4.130

9.  Hyperbaric oxygen therapy for the treatment of radiation-induced macular ischemia.

Authors:  Shamim A Haji; Ronald Ep Frenkel
Journal:  Clin Ophthalmol       Date:  2010-05-14

Review 10.  Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas.

Authors:  Anudeep Yekula; Koushik Muralidharan; Zachary S Rosh; Anna E Youngkin; Keiko M Kang; Leonora Balaj; Bob S Carter
Journal:  Adv Biosyst       Date:  2020-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.